A phase II trial of intraperitoneal EGEN-001, an interleukin (IL)-12 plasmid formulated with PEG-PEI-cholesterol lipopolymer in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer: A GOG study

✍ Scribed by Alvarez, R.D.; Sill, M.; Davidson, S.A.; Muller, C.; Bender, D.P.; DeBernardo, R.; Behbakht, K.; Huh, W.K.

• Book ID: 127353687
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 94 KB
• Volume: 133
• Category: Article
• ISSN: 0090-8258
• DOI: 10.1016/j.ygyno.2014.03.117